Life Cycle Investment Partners Ltd

Position in ARGX — Argenx SE

CIK 2072459 LONDON, X0

Position in ARGX

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$42,987,626

+$4,450,252 QoQ

Shares Held

58,867

+28.5% QoQ

Ownership

0.095%

of shares outstanding

% of Portfolio

0.28%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Life Cycle Investment Partners Ltd holds $298,390,850 across 3 Biotechnology names. ARGX ranks #3 (14.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	440,409	$196,660,234
2	ALNY	Alnylam Pharmaceuticals, Inc.	177,541	$58,742,990
3	ARGX	Argenx SE This page	58,867	$42,987,626

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$42,987,626	58,867	+28.5%	Shares	Sole	2026-05-12
2025-12-31	$38,537,374	45,826	—	Shares	Sole	2026-02-09
No filing history on record for this holder in this stock.